InvestorsHub Logo
Followers 21
Posts 3704
Boards Moderated 0
Alias Born 09/25/2012

Re: eb0783 post# 265113

Friday, 05/27/2016 2:01:57 AM

Friday, May 27, 2016 2:01:57 AM

Post# of 346001

A doubling of median overall survival (OS) in both bavituximab-containing arms compared to the control arm and a statistically significant improvement in overall survival

If this is FACT, why did they not submit this data to FDA. And of course your "facts" were neutered by the Sunrise results (first lookin trial stoppage for futility). The Sunrise failure facts are much more valid give they were from a much larger trial rather than the botched PII with tiny group and highly censored. The PIII goal was to validate or invalidate the PII results - they were resoundingly invalidated.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News